Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Sensus Healthcare, Inc. (SRTS : NSDQ)
 
 • Company Description   
Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida.

Number of Employees: 54

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.44 Daily Weekly Monthly
20 Day Moving Average: 63,858 shares
Shares Outstanding: 16.44 (millions)
Market Capitalization: $73.02 (millions)
Beta: 1.29
52 Week High: $9.33
52 Week Low: $4.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -6.33% -11.04%
12 Week -5.13% -17.37%
Year To Date -35.84% -40.07%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
851 BROKEN SOUND PARKWAY NW SUITE 215
-
BOCA RATON,FL 33487
USA		 ph: 561-922-5808
fax: 561-948-2071		 tpatel@allianceadvisors.com http://www.sensushealthcare.com
 
 • General Corporate Information   
Officers
Joseph Sardano - Chief Executive Officer and Chairman
Javier Rampolla - Chief Financial Officer
Megan Cornish - Director
William H. McCall - Director
Anthony B. Petrelli - Director

Peer Information
Sensus Healthcare, Inc. (ABMD)
Sensus Healthcare, Inc. (DMDS)
Sensus Healthcare, Inc. (CPWY.)
Sensus Healthcare, Inc. (EQUR)
Sensus Healthcare, Inc. (ECIA)
Sensus Healthcare, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 81728J109
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
Share - Related Items
Shares Outstanding: 16.44
Most Recent Split Date: (:1)
Beta: 1.29
Market Capitalization: $73.02 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.07 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.11 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/14/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 40.36
Trailing 12 Months: 44.40
PEG Ratio: -
Price Ratios
Price/Book: 1.38
Price/Cash Flow: 10.28
Price / Sales: 1.85
EPS Growth
vs. Year Ago Period: -214.29%
vs. Previous Quarter: -277.78%
Sales Growth
vs. Year Ago Period: -21.75%
vs. Previous Quarter: -36.14%
ROE
06/30/25 - -
03/31/25 - 3.34
12/31/24 - 12.42
ROA
06/30/25 - -
03/31/25 - 3.00
12/31/24 - 11.20
Current Ratio
06/30/25 - -
03/31/25 - 8.06
12/31/24 - 9.64
Quick Ratio
06/30/25 - -
03/31/25 - 5.74
12/31/24 - 7.36
Operating Margin
06/30/25 - -
03/31/25 - 4.56
12/31/24 - 15.90
Net Margin
06/30/25 - -
03/31/25 - 4.56
12/31/24 - 15.90
Pre-Tax Margin
06/30/25 - -
03/31/25 - 8.76
12/31/24 - 21.58
Book Value
06/30/25 - -
03/31/25 - 3.22
12/31/24 - 3.41
Inventory Turnover
06/30/25 - -
03/31/25 - 1.18
12/31/24 - 1.13
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©